Anesthesia Injection Franchise in Ahmedabad

Thiopental Sodium Injection Supplier in Mumbai

General Anesthetic Injection Distributor in Delhi

Critical Care Injection Manufacturer in Bangalore

Surgical Anesthesia Injection Stockist in Hyderabad
Thiopental Injection Exporter in Chandigarh

Home/Products /thiopental-sodium-500mg-injection

Thiopent 500 Injection

Composition : Thiopental Sodium (500mg) Injection

Dosage Form : Injection

Packaging Type : Vial

Packaging : 500mg

Price : ₹1/-

Thiopental Sodium 500mg injection is a short-acting intravenous anesthetic agent used for the effective induction of general anesthesia and procedural sedation in hospital and surgical settings.

It works by rapidly depressing central nervous system activity, producing quick onset unconsciousness and sedation, allowing smooth initiation of anesthesia before surgical intervention.

This injection is commonly administered in operative procedures, emergency surgeries, intensive care management, and seizure control under medical supervision, ensuring reliable anesthetic depth and rapid clinical response.

With fast action profile, dependable anesthetic performance, and strong utilization in critical care environments, this formulation strengthens an anesthesia product portfolio and supports consistent demand in surgical and emergency healthcare management.

Read More

About the Product

Thiopental Sodium 500mg injection is a short-acting intravenous anesthetic agent used for the effective induction of general anesthesia and procedural sedation in hospital and surgical settings.

It works by rapidly depressing central nervous system activity, producing quick onset unconsciousness and sedation, allowing smooth initiation of anesthesia before surgical intervention.

This injection is commonly administered in operative procedures, emergency surgeries, intensive care management, and seizure control under medical supervision, ensuring reliable anesthetic depth and rapid clinical response.

With fast action profile, dependable anesthetic performance, and strong utilization in critical care environments, this formulation strengthens an anesthesia product portfolio and supports consistent demand in surgical and emergency healthcare management.

Possible side effects include respiratory depression, hypotension, slow heart rate, excessive sedation, coughing, or irritation at the injection site. Rarely, allergic reactions or prolonged recovery from anesthesia may occur. Continuous monitoring is necessary during administration to ensure patient safety.

It helps in rapid induction of general anesthesia before surgical operations and diagnostic procedures. It is also indicated for short surgical interventions, management of refractory seizures, sedation during emergency care, and reduction of elevated intracranial pressure in critical neurological conditions under specialist supervision.

Thiopent 500 Injection should be administered only by trained anesthesiologists or healthcare professionals in a hospital or critical care environment. Proper monitoring of breathing, blood pressure, and cardiac function is essential. Use cautiously in patients with liver disease, respiratory disorders, cardiovascular instability, or known sensitivity to barbiturates.

Store below 25°C in a dry place away from direct light and moisture. Keep the vial properly sealed and out of reach of children. The prepared solution should be used immediately after reconstitution as per recommended medical guidelines.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation